• Chart
  • Rating
  • Financials
  • Technicals
  • Volume
  • Result
  • Synopsis
  • Corp Action
  • MF Shareholding
  • Similar Stocks
  • FAQs
    1. Home
    2. Stocks
    3. Windlas Share Price

    Windlas Biotech Share PriceWindlas Biotech

    Small Cap 5.6k Result
    ₹356.55
    1.5 (0.42%)
    As on 30 September, 2023 | 06:06 BSE: 543329 NSE: WINDLASISIN: INE0H5O01029

    Windlas Biotech Performance

    Day Range

    • Low 352.35
    • High 360
    356.55

    52 Week Range

    • Low 212
    • High 420.9
    356.55
    • Open Price355.05
    • Previous Close355.05
    • Volume21725

    Start SIP in Windlas Biotech

    Start SIP

    Windlas Biotech Share Price

    • Over 1 Month -0.14%
    • Over 3 Month 16.75%
    • Over 6 Month 58.64%
    • Over 1 Year 54.82%

    Windlas Biotech Key Statistics

    P/E Ratio 16.5
    PEG Ratio 1.8
    Market Cap Cr 742
    Price to Book Ratio 1.8
    EPS 19.7
    Dividend 1.1
    Relative Strength Index 48.04
    Money Flow Index 56.22
    MACD Signal -1.06
    Average True Range 13.08

    Windlas Biotech Investment Rating

    • Master Rating:

    • Windlas Biotech has an operating revenue of Rs. 537.93 Cr. on a trailing 12-month basis. An annual revenue growth of 11% is good, Pre-tax margin of 11% is healthy, ROE of 10% is good. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is trading close to its 50DMA and comfortably placed above its 200DMA, around 24% above 200DMA. It needs to take support around the 50 DMA level to continue further upside move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 48 which is a POOR score indicating inconsistency in earnings, a RS Rating of 72 which is FAIR indicating the recent price performance, Buyer Demand at B+ which is evident from recent demand for the stock, Group Rank of 40 indicates it belongs to a strong industry group of Medical-Ethical Drugs and a Master Score of B is close to being the best. Institutional holding has declined in the last reported quarter is a negative sign. Overall, the stock has mediocre technical strength and poor fundamentals, there are superior stocks in the current market environment.

    EPS Strength

    Price Strength

    Buyer Demand

    Group Rank

    Windlas Biotech Financials
    IndicatorJun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022
    Oper Rev Qtr Cr 145141120133120122
    Operating Expenses Qtr Cr 128124106117106108
    Operating Profit Qtr Cr 171614161414
    Depreciation Qtr Cr 343333
    Interest Qtr Cr 000000
    Tax Qtr Cr 44434-1
    Net Profit Qtr Cr 12119121015
    IndicatorMar 2023Mar 2022
    Total Revenue Annual Cr 523473
    Operating Expenses Annual Cr 453413
    Operating Profit Annual in Cr 6053
    Depreciation Cr 1212
    Interest Annual Cr 11
    Tax Annual Cr 147
    Net Profit Annual Cr 4339
    IndicatorMar 2023Mar 2022
    Cash from Operating Activity Annual Cr 9
    Cash from Investing Activity Annual Cr -154
    Cash from Financing Annual Activity Cr 130
    Net Cash Flow Annual Cr -15
    IndicatorMar 2023Mar 2022
    Total ShareHolders Funds Annual Cr 403395
    Fixed Assets Annual Cr 12499
    Total Non Current Assets Annual Cr 175109
    Total Current Assets Annual Cr 354382
    Total Assets Annual Cr 529491
    IndicatorMar 2023Mar 2022
    Book Value Per Share Annual Rs 192181
    ROE Annual % 1110
    ROCE Annual % 1412
    Total Debt to Total Equity Annual --
    EBDIT Annual Margin % 1413
    IndicatorJun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022
    Oper Rev Qtr Cr 145141120133120122
    Operating Expenses Qtr Cr 128124106117106108
    Operating Profit Qtr Cr 171614161414
    Depreciation Qtr Cr 343333
    Interest Qtr Cr 000000
    Tax Qtr Cr 44434-1
    Net Profit Qtr Cr 12119121015
    IndicatorMar 2023Mar 2022
    Total Revenue Annual Cr 523473
    Operating Expenses Annual Cr 453414
    Operating Profit Annual in Cr 6052
    Depreciation Cr 1212
    Interest Annual Cr 11
    Tax Annual Cr 147
    Net Profit Annual Cr 4338
    IndicatorMar 2023Mar 2022
    Cash from Operating Activity Annual Cr 9
    Cash from Investing Activity Annual Cr -155
    Cash from Financing Annual Activity Cr 130
    Net Cash Flow Annual Cr -15
    IndicatorMar 2023Mar 2022
    Total ShareHolders Funds Annual Cr 402395
    Fixed Assets Annual Cr 12499
    Total Non Current Assets Annual Cr 175113
    Total Current Assets Annual Cr 354378
    Total Assets Annual Cr 529491
    IndicatorMar 2023Mar 2022
    Book Value Per Share Annual Rs 192181
    ROE Annual % 1110
    ROCE Annual % 1412
    Total Debt to Total Equity Annual --
    EBDIT Annual Margin % 1413

    Windlas Biotech Technicals

    EMA & SMA

    Current Price
    ₹356.55
    1.5 (0.42%)
    • Bullish Moving Average
    • ___
    • 10
    • Bearish Moving Average
    • ___
    • 6
    • 20 Day
    • ₹359.32
    • 50 Day
    • ₹352.41
    • 100 Day
    • ₹330.5
    • 200 Day
    • ₹303.25
    • 20 Day
    • ₹364.79
    • 50 Day
    • ₹358.45
    • 100 Day
    • ₹325.04
    • 200 Day
    • ₹286.62

    Windlas Biotech Resistance and Support

    PIVOT
    ₹356.3
    Resistance
    First Resistance ₹360.25
    Second Resistance ₹363.95
    Third Resistance ₹367.9
    RSI 48.04
    MFI 56.22
    MACD Single Line -1.06
    MACD -2.88
    Support
    First Resistance ₹352.6
    Second Resistance ₹348.65
    Third Resistance ₹344.95

    Windlas Biotech Delivery and Volume

    Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
    Day 23,976 1,391,807 58.05
    Week 33,690 1,892,042 56.16
    1 Month 59,491 2,853,781 47.97
    6 Month 87,454 3,848,842 44.01

    Windlas Biotech Result Highlights

    Windlas Biotech Synopsis

    NSE-Medical-Ethical Drugs

    Windlas Biotech belongs to the Industry of Pharmaceuticals. Company’s Total Operating Revenue is Rs. 513.08 Cr. and Equity Capital is Rs. 10.46 Cr. for the Year ended 31/03/2023. Windlas Biotech Ltd. is a Public Limited Listed company incorporated on 19/02/2001 and has its registered office in the State of Uttarakhand/Uttaranchal, India. Company’s Corporate Identification Number(CIN) is L74899UR2001PLC033407 and registration number is 033407.
    Market Cap 742
    Sales 538
    Shares in Float 0.77
    No of funds 11
    Yield 1.12
    Book Value 1.85
    U/D Vol ratio 1.7
    LTDebt / Equity
    Alpha 0.15
    Beta 0.56

    Windlas Biotech

    Owner NameJun-23Apr-23Mar-23Feb-23
    Promoters 62.82%62.44%62.38%61.22%
    Mutual Funds 10.51%10.65%10.64%11.32%
    Foreign Portfolio Investors 0.8%1.23%1.32%1.4%
    Financial Institutions/ Banks 0.04%0.04%0.04%0.04%
    Individual Investors 22.01%22%21.98%22.18%
    Others 3.82%3.64%3.64%3.84%

    Windlas Biotech Management

    Name Designation
    Mr. Vivek Dhariwal Chairman & Ind.Director
    Mr. Hitesh Windlass Managing Director
    Mr. Manoj Kumar Windlass Joint Managing Director
    Mr. Pawan Kumar Sharma Executive Director
    Mr. Ashok Kumar Windlass Whole Time Director
    Mrs. Prachi Jain Windlass Non Executive Director
    Mr. Srinivasan Venkataraman Ind. Non-Executive Director
    Mr. Gaurav Gulati Ind. Non-Executive Director

    Windlas Biotech Forecast

    Price Estimates

    2,000(9.8%)
    1,758(-3.5%)
    1,590(-12.7%)

    Other Analyst Rating

    Windlas Biotech Corporate Action

    Date Purpose Remarks
    2023-08-08 Quarterly Results
    2023-05-05 Audited Results & Final Dividend
    2023-02-08 Quarterly Results
    2022-11-08 Quarterly Results
    2022-08-04 Quarterly Results

    Windlas Biotech MF Shareholding

    Name Amount(cr)
    ICICI Prudential Smallcap Fund Growth 6989
    ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Growth 3174
    UTI Healthcare Fund Regular Plan Growth 776
    Sundaram Emerging Small Cap Ser VII Regular Transfer Inc Dist cum Cap Wdrl 160
    Sundaram L/T Micro cap Tax Advantage Fund Sries III Regular Growth 78
    • Company Name
    • CMP
    • Chg(%)
    • Company Name
    • CMP
    • Chg(%)

    Windlas Biotech FAQs

    What is Share Price of Windlas Biotech ?

    Windlas Biotech share price is ₹356 As on 30 September, 2023 | 05:52

    What is the Market Cap of Windlas Biotech ?

    The Market Cap of Windlas Biotech is ₹741.6 Cr As on 30 September, 2023 | 05:52

    What is the P/E ratio of Windlas Biotech ?

    The P/E ratio of Windlas Biotech is 16.5 As on 30 September, 2023 | 05:52

    What is the PB ratio of Windlas Biotech ?

    The PB ratio of Windlas Biotech is 1.8 As on 30 September, 2023 | 05:52

    Q2FY23

    More Information

    CIN: L67190MH2007PLC289249 | Stock Broker SEBI Regn.: INZ000010231 | SEBI RA Regn.: INH000004680 | SEBI Depository Regn.: IN DP CDSL: IN-DP-192-2016 | AMFI REGN No.: ARN-104096 | NSE Member id: 14300 | BSE Member id: 6363 | MCX Member ID: 55945 | Investment Adviser Regn No: INA000014252 | Registered Address - IIFL House, Sun Infotech Park, Road no. 16V, Plot no. B-23, MIDC, Thane Industrial Area, Waghle Estate, Thane, Maharashtra - 400604

    *Brokerage will be levied flat fee/executed order basis and not on a percentage basis. Flat fee of Rs. 10/order is available with Power Investor & Ultra Trader Packs. Investment in securities market are subject to market risk, read all related documents carefully before investing. Digital account would be opened after all procedure relating to IPV and client due diligence is completed. If sale/ purchase value of share of Rs.10/- or less, a maximum brokerage of 25 paisa per share may be collected. Brokerage will not exceed the SEBI prescribed limit.

    Compliance Officer: Ms. Namita Godbole, Email: support@5paisa.com, Support desk helpline: 8976689766

    Contact Us

    Attention Investors

    • 1. No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.
    • 2. Message from Exchange(s): Prevent Unauthorised transactions in your account --> Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day. Issued in the interest of investors.
    • 3. Message from Depositories: a) Prevent Unauthorized Transactions in your demat account --> Update your mobile number with your Depository Participant. Receive alerts on your registered mobile for all debit and other important transactions in your demat account directly from CDSL on the same day issued in the interest of investors. b) KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
    ©2023, 5Paisa Capital Ltd. All Rights Reserved.
    We are ISO 27001:2013 Certified.